Torrie Fields, MPH
Chief Executive Officer
Torrie Fields serves as Chief Executive Officer of Votive Health. Her experience has encompassed work as an economist and population health researcher in a variety of settings, including health plans, health delivery systems, local and federal health departments. Prior to founding Votive, Torrie oversaw serious illness strategy and value based care at Blue Shield of California and Cambia Health Solutions, scaling complex accountable health and quality measurement programs across all lines of business. She is considered a thought leader in value based care and payment models for people with complex and serious health conditions and has been recognized internationally for her work in value-based payment and performance-based incentives.
Torrie holds a Master’s in Public Health in health management and policy from Oregon Health and Sciences University, a Bachelor of Science degree in sociology from Portland State University, a Bachelor of Arts degree in communication from University of California, San Diego, and a Certificate in Gerontology from Portland Community College. Torrie serves as strategic advisor to the Center to Advance Palliative Care (CAPC), Coalition to Transform Advanced Care (C-TAC), and National Academy for State Health Policy (NASHP). She serves on the board of Housecall Providers, the Social Work Hospice and Palliative Network, and The Better Care Playbook Advisory Group. She serves on the Centers for Medicare and Medicaid Services (CMS) Core Measures Committee and on the Palliative Care Technical Expert Panel for the Medicare Quality Payment Program.
SVP, Finance & Pricing
Tom Wortman is the Head of Finance and Pricing for Votive Health, where he provides strategic input for the Company’s financial, actuarial, and data analytics functions. Tom is committed to achieving Votive Health’s vision of vastly improving care for people with serious illness by providing a higher quality experience for members, their families, providers and health plans.
Tom brings a wealth of health care industry knowledge and leadership to Votive. Prior to joining the company, he held various Actuarial/Financial leadership roles with Cambia Health Solutions / Regence Blue Cross Blue Shield, the last several years as VP of Government Programs Actuarial. Tom was a consultant at Milliman USA prior to joining Cambia. Tom holds a Bachelor’s of Science in Mathematics from the University of Idaho.
Sid Khanijou JD, MPH
General Counsel & VP, Accountable Health Strategy
Sid Khanijou is General Counsel & VP, Accountable Health Strategy at Votive Health. He has spent his career seeking to transform the healthcare industry and brings multidisciplinary experience having worked at physician advocacy organizations, pharmaceutical companies, local government, and health plans. Sid routinely negotiates complex commercial contracts, provides cutting-edge strategic counsel, and proactively advises clients on opportunities and risk with an eye towards the industry’s evolving regulatory landscape. He understands the incentives that drive healthcare decision-making, and helps institutions and policymakers develop innovative payment models that align value and create the best outcomes for payers, providers, and patients.
Prior to Votive, Sid was at Cambia Health Solutions where he served as Senior Associate General Counsel to lead support of transactional, regulatory, and litigation matters related to Cambia's provider and pharmacy benefit manager (PBM) relationships, which included negotiating value-based (population health) arrangements, warranty and rebate arrangements, and other network agreements with health systems, management services organizations and other risk-bearing intermediaries. He also worked as counsel at Aetna where he provided broad legal support for its domestic (Medicare and Retiree Markets) and international (Aetna International) business units and insurance operations.
Sid holds a juris doctor (JD) from DePaul University College of Law, a master of public health (MPH) from Harvard School of Public Health, and a bachelor's degree (BA) in cognitive science from Occidental College.
Tyler Perkins joined Votive Health in September 2021 as Vice President, Growth with the vision to scale the company across all markets along with developing and refining new and existing strategies to support and drive growth and expansion via new business opportunities.
Prior to joining Votive, Tyler was Executive Director of Business Development & Provider Relations at Hosparus Health, a leading non-profit hospice and palliative care provider in Louisville, KY. As part of the national Value-Based Insurance Design (VBID) demonstration launched in 2021 by CMS, Tyler was successful in enrolling Hosparus into this demonstration to provide hospice and palliative care services to patients on Medicare Advantage plans in Kentucky and Indiana. Previously, Tyler worked for 6 years at ChenMed, where patient membership increased from 15,000 to 60,000 during his tenure and reimbursement was under a global capitated arrangement.
Tyler holds an M.B.A. from Indiana Wesleyan University and a B.S. in Biology from the University of Kentucky. He was a 2015 Healthcare Fellow for the Health Enterprise Network in Louisville and is currently a Board of Trustee for the Multiple Sclerosis Society for the KY, IN and TN chapter.
VP, Value-Based Care
Gina M. Bruno is joining Votive Health as our Vice President, Value-Based Care. Gina joins from naviHealth, where she served as Vice President of Value-Based Care. She is considered a thought leader in value-based care and in managing change in clinical settings. Prior to joining naviHealth in 2015, Gina worked at Booz Allen Hamilton in Washington, DC, where she led strategy and transformation engagements as a certified Change Management Advanced Practitioner.
Gina has a BA from Harvard and MBA from Vanderbilt University where she completed an internship at Massachusetts General Hospital and independent studies in senior living, palliative care, and hospice, including consultative work for a hospice provider in Botswana.
Directors and Advisors
Dan Gebremedhin, MD
Dan Gebremedhin, MD is a Partner at Flare Capital Partners and serves on the Board of Flare portfolio companies Eden Health and Somatus. Prior to joining Flare Capital, Dan served as a Medical Director at the Harvard Pilgrim Health Plan. Dan spent over 8 years as a practicing Internal Medicine Physician on the Faculty of the Massachusetts General Hospital and Instructor in Medicine at Harvard Medical School, after completing Internal Medicine Residency at the Massachusetts General Hospital in 2010. Dan served on Massachusetts Governor Charlie Baker’s Board of Nursing Home Administrators from 2016 to 2020. He has served as a Senior Health Policy Advisor for the Campaigns of Governor Charlie Baker, Congressman Joseph Kennedy III and Congressman Jake Auchincloss. Dan earned a B.S. from the University of California, San Diego, an M.D. from the Morehouse School of Medicine, and an M.B.A. from the Harvard Business School.
David A. Jones, Jr.
David A. Jones, Jr. is one of the leading venture capitalists in mid-America and a well-respected voice in healthcare business and innovation. He founded Chrysalis in 1993, after realizing that the absence of resident venture capital managers in Mid-America represented an opportunity to find and partner with promising growth companies in the region. He currently focuses primarily on healthcare investing and chairs the management company and funds’ investment committees.
David is active in civic and charitable affairs on both national and local levels. Recognizing the critical role education plays in catalyzing American innovation and competitiveness, as well as its potential to improve public health, David served as an elected member of the Jefferson County (KY) Board of Education (2012-2016) and as its chair for two years. He is a director of the Humana Foundation, which focuses on social determinants of health as a means of enhancing health equity, and of the C.E. & S. Foundation, which focuses on improving access and outcomes in P-16 education.
David has served as adjunct professor at Georgetown University in Washington, DC (constitutional and foreign affairs law) and at University of Louisville (entrepreneurship), and is currently an adjunct professor of innovation at Bellarmine University in Louisville. David lectures frequently in Chrysalis’ region on topics related to venture capital and the changing healthcare industry.
Bob Saunders is a General Partner of OCA Ventures and chairs its healthcare investing activity. He represents OCA on the boards of mPulse, ReGroup Therapy and HealthiPass. He is also a Co-Founder and Chairman of XLerateHealth, a healthcare accelerator in Louisville, KY.
Prior to OCA, Bob was a Senior Managing Director and General Partner at Chrysalis Ventures (Louisville) from 1997 to 2009 and served as a Senior Advisor to Chrysalis from 2009-2010. He was also co-founder of Saunders Murdock and Associates, a life science “super-angel” investor, and a Senior Managing Director at Providian Capital Management from 1993-1997. He began his career in business strategy consulting and worked with both The Boston Consulting Group and Bain & Co.
Over the last 30 years, he has invested in several dozen startup companies and has mentored 100+ startups.
Bob received a B.A. from Stanford University, an M.Sc. from the London School of Economics, and an M.A. from Harvard University. Bob is both a Fulbright Scholar and a Marshall Scholar.
Mark Morse, MBA
Mark Morse is a technology advisor to Votive Health where he provides strategic input on technology platforms, tools and analytics.
In his current role, Mark serves as CEO at Enclara Pharmacia. Enclara is the nation’s largest hospice PBM providing services to over 450 hospice organizations and their patients across the country. In his role, Mark is responsible for all aspects of the company’s strategy development and execution, operational performance, sales and P&L.
Prior to his role as CEO, Mark held several roles in the company include leading Pharmacy Service Operations, PBM sales and client services of integrated medical/Rx business, Corporate Sales Director for National & Major Account and product innovation work focused on consumer driven solutions.
Prior to joining Humana in 2001, Mark spent six years with UnitedHealth Group serving as the business owner for its consumer portal and operations director for health plan and systems migration.
Veeral Desai is a seasoned healthcare executive with a deep passion for healthcare delivery and transformation. Mr. Desai has served as agilon health's President, Enterprise Operations. At agilon, he has played a broad role in the development of the company. He led the creation of agilon’s operating platform and has held operating responsibility spanning the Western and Eastern regions of the company. As Chief Strategy and Development Officer, he leads business development, corporate strategy, new market implementation, and product development for the company. In April 2021, agilon health became a public company (NYSE: AGL).
Prior to agilon, Mr. Desai served in several senior executive roles at Vantage Oncology, a leader in community oncology and value-based cancer care. As President of Operations, he oversaw the growth and development of Vantage into a leading national cancer delivery network. Mr. Desai helped incubate and served as Chief Operating Officer of the Vantage Cancer Care Network, an innovative model for value-based care delivery in the management of cancer populations. Vantage Oncology was acquired by McKesson Corporation in 2016.
Before joining Vantage, Mr. Desai spent nearly a decade as a leader in the healthcare practice of Bain & Company. He also served on the Board of Directors of The Oncology Institute of Hope and Innovation, a national leader in value-based oncology care, which became a public company in November 2021 (NASDAQ: TOI). Mr. Desai received a Bachelors of Science in Business Administration from the University of California, Berkeley and his Masters in Business Administration from the Harvard Business School.